New hope for targeted treatment of obstructive hypertrophic cardiomyopathy: comment on the EXPLORER-HCM trial

Eur Heart J. 2020 Nov 7;41(42):4089-4090. doi: 10.1093/eurheartj/ehaa801.

Authors

Leonarda Galiuto¹, Carlo Patrono²

Affiliations

¹ Department of Cardiology, Fondazione Policlinico A.Gemelli-IRCSS, Catholic University of the Sacred Heart, Policlinico A. Gemelli, Largo A. Gemelli 8, Rome, Italy.
² Adjunct Professor of Pharmacology, Catholic University, School of Medicine, Italy and Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.

PMID: 33099599
DOI: 10.1093/eurheartj/ehaa801

No abstract available

Publication types

Comment

MeSH terms

Benzylamines*
Cardiomyopathy, Hypertrophic* / drug therapy
Double-Blind Method
Humans
Uracil / analogs & derivatives

Substances

Benzylamines
MYK-461
Uracil